Stuart Therapeutics Announces Completion of Phase 3 Dry Eye Disease Clinical Trial
STUART, Fla., Jan. 21, 2025 /PRNewswire/ -- Stuart Therapeutics, Inc. (Stuart), a clinical-stage drug platform company developing novel therapies for ophthalmic diseases, today announced last patient last visit in the